<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of the P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> which is associated with the development of multidrug resistance in various cell lines was investigated in 87 fresh <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> samples using the specific mouse monoclonal antibody MRK16 in an indirect immunofluorescence assay </plain></SENT>
<SENT sid="1" pm="."><plain>Considering a 10% positive cell cut-off value, a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> expression of P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> was observed in 5/22 (22.7%) de novo <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath>, 7/22 (31.8%) relapse or secondary <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath>, 14/27 (51.8%) <z:hpo ids='HP_0011009'>acute</z:hpo> transformation of myeloproliferative or <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and 5/16 (31.2%) <z:hpo ids='HP_0006775'>multiple myelomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This expression was not associated with specific cytogenetic abnormalities, especially alterations of chromosome 7q </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="1" ids="9948">Verapamil</z:chebi>, a <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi>, has been demonstrated to circumvent the multidrug resistance in cell lines, possibly by interfering with P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> function </plain></SENT>
<SENT sid="4" pm="."><plain>Using the microculture tetrazolium assay, <z:chebi fb="1" ids="9948">verapamil</z:chebi> was demonstrated to increase the sensitivity of fresh leukaemic or <z:mp ids='MP_0009440'>myeloma</z:mp> cells to <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> in 19/43 (43.1%) samples </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> IC50 level and the capacity of <z:chebi fb="1" ids="9948">verapamil</z:chebi> to increase the sensitivity of blast cells to <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> in vitro did not correlate with the expression of P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that high non-cytotoxic concentrations of <z:chebi fb="1" ids="9948">verapamil</z:chebi> were able to increase the in vitro <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> sensitivity of fresh <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:mp ids='MP_0009440'>myeloma</z:mp> cells without detectable expression of the P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> </plain></SENT>
</text></document>